SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JustInTime who wrote (6874)1/11/1999 1:57:00 PM
From: Waldeen  Read Replies (1) of 90042
 
Gene Logic (GLGC) deal with Affymetrix(AFFX)

biz.yahoo.com

text follows,

Gene Logic, Affymetrix strike deal
SANTA CLARA, Calif. Jan 11 (Reuters) - Affymetrix Inc. and Gene Logic Inc. said in a joint announcement Monday that Gene Logic has agreed to begin selling databases of gene information that are based on Affymetrix's GeneChip technology.

Gen Logic is the first company to use Affymetrix's GeneChiptechnology in databases. It plans to sell the products to pharmaceutical and biotechnology companies for their use in developing drugs that use differing forms of gene expression.

Gene Logic will receive annual subscription fees from database users. It will pay Affymetrix annual fees and after a commercial milestone is achieved, also pay royalties. Further financial details were undisclosed.

Gene Logic's stock was up 1 at 7-5/8 by mid-morning. Affymetrix climbed 7/8 to 28. Both company stocks are traded on the Nasdaq stock exchange.

also,

biz.yahoo.com

company overview from todays Washington Post

washingtonpost.com

stopped out of OMPT at 13 1/6 looking to enter GLGC here on the dip to 7 3/8... what do you think Tim?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext